Visionary Holdings signs strategic partnership with Qianxin Bocheng

HONG KONG - Visionary Holdings (Asia) Limited, a wholly owned subsidiary of Visionary Holdings Inc. (NASDAQ:GV), a micro-cap company with a market value of $7.86 million and annual revenue of $7.77 million, has entered into a strategic cooperation agreement with Qianxin Bocheng (Jiangsu) Technology Development Co., Ltd., according to a press release issued Wednesday. InvestingPro data shows the company’s shares have declined 13% year-to-date.

The three-year partnership focuses on developing the aesthetic treatment industry through four key areas: industrial park cooperation, project incubation, enterprise cultivation, and brand promotion activities.

Under the agreement, Qianxin Bocheng will provide industrial park facilities, policy support, and related services, while Visionary Holdings will leverage its capital resources and international experience to bring in enterprises across the aesthetic treatment value chain.

The companies plan to establish a joint working group to implement the partnership, with regular high-level meetings to review progress and make strategic decisions.

Xiyong Hou, Chief Executive Officer of Visionary Holdings Inc., called the cooperation "an important step in strengthening GV’s presence in the aesthetic treatment industry."

The agreement includes provisions for Visionary Holdings to have priority in acquiring or investing in high-quality projects identified through the partnership. Both parties will also organize industry events to enhance their influence in the sector.

The partnership aims to create a specialized industrial park for aesthetic treatment companies while leveraging industrial investment funds to accelerate the growth of promising startups in the sector. According to InvestingPro analysis, GV appears undervalued at current levels, despite its weak financial health score, suggesting potential upside for investors interested in the company’s expansion plans. For detailed valuation metrics and additional insights, check out the Most Undervalued Stocks list.

In other recent news, Visionary Holdings Inc. has entered into a strategic partnership with Jiangsu Yike Regenerative Medicine. The collaboration focuses on research and development in the areas of cellular rejuvenation and aesthetic treatment. Under the terms of the agreement, Yike will lead and finance the research projects, taking charge of securing related intellectual property. Visionary Holdings will have the option to acquire or license these rights based on market potential. Consideration for these rights will be paid in cash or Visionary Holdings shares. This partnership highlights Visionary Holdings’ ongoing efforts to expand its footprint in the medical aesthetics field. These developments are part of the company’s recent strategic initiatives.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.